• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺腺癌中异常的 OCIAD2 去甲基化与预后相关。

Aberrant OCIAD2 demethylation in lung adenocarcinoma is associated with outcome.

机构信息

Department of Pathology, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.

Department of Thoracic Surgery, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan.

出版信息

Pathol Int. 2022 Oct;72(10):496-505. doi: 10.1111/pin.13262. Epub 2022 Aug 3.

DOI:10.1111/pin.13262
PMID:35920378
Abstract

Overexpression of OCIAD2 in lung adenocarcinoma has already been reported in several research articles, but the molecular mechanism involved remains unknown. Promoter CpG methylation is a representative form of epigenetic gene regulation, and a considerable number of tumor suppressor genes show hypermethylation in many cancers. In contrast, promoter CpG hypomethylation causes oncogene overexpression, resulting in carcinogenesis and malignant progression. In the present study, we investigated the CpG methylation and expression status of OCIAD2 using tumor tissues and adjacent normal tissues from seven cases of lung adenocarcinoma. We also examined the relationship between CpG methylation status and outcome in 58 patients with adenocarcinoma. Pyrosequencing showed that CpG sites in OCIAD2 promoter regions were more frequently demethylated in tumor tissues than in adjacent normal tissues, and reverse transcription-quantitative polymerase chain reaction revealed overexpression of OCIAD2 in lung adenocarcinoma. There was a correlation between OCIAD2 CpG demethylation and the level of mRNA expression, and statistical analysis showed that CpG hypomethylation of OCIAD2 was associated with poor outcomes. Our results suggest that overexpression of OCIAD2 might be caused mainly by CpG hypomethylation and that OCIAD2 methylation status might be a useful prognostic indicator in lung adenocarcinoma.

摘要

OCIAD2 在肺腺癌中的过表达已在几项研究中报道,但涉及的分子机制尚不清楚。启动子 CpG 甲基化是表观遗传基因调控的一种代表性形式,许多肿瘤抑制基因在许多癌症中表现出过度甲基化。相比之下,启动子 CpG 低甲基化导致癌基因过表达,导致癌变和恶性进展。在本研究中,我们使用来自 7 例肺腺癌的肿瘤组织和相邻正常组织研究了 OCIAD2 的 CpG 甲基化和表达状态。我们还检查了 58 例腺癌患者中 CpG 甲基化状态与结局的关系。焦磷酸测序显示,OCIAD2 启动子区域的 CpG 位点在肿瘤组织中比在相邻正常组织中更频繁地去甲基化,逆转录定量聚合酶链反应显示 OCIAD2 在肺腺癌中过表达。OCIAD2 CpG 去甲基化与 mRNA 表达水平之间存在相关性,统计分析显示 OCIAD2 的 CpG 低甲基化与不良预后相关。我们的结果表明,OCIAD2 的过表达可能主要是由 CpG 低甲基化引起的,OCIAD2 甲基化状态可能是肺腺癌的一个有用的预后指标。

相似文献

1
Aberrant OCIAD2 demethylation in lung adenocarcinoma is associated with outcome.肺腺癌中异常的 OCIAD2 去甲基化与预后相关。
Pathol Int. 2022 Oct;72(10):496-505. doi: 10.1111/pin.13262. Epub 2022 Aug 3.
2
Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.在肺腺癌中,异常的层粘连蛋白过表达受肿瘤相关 CpG 去甲基化的调节。
Am J Pathol. 2012 Apr;180(4):1653-62. doi: 10.1016/j.ajpath.2011.12.014. Epub 2012 Feb 4.
3
Prognostic significance of promoter CpG island hypermethylation and repetitive DNA hypomethylation in stage I lung adenocarcinoma.启动子CpG岛高甲基化和重复DNA低甲基化在Ⅰ期肺腺癌中的预后意义
Virchows Arch. 2015 Jun;466(6):675-83. doi: 10.1007/s00428-015-1749-0. Epub 2015 Mar 13.
4
Ovarian carcinoma immunoreactive antigen domain 2 controls mitochondrial apoptosis in lung adenocarcinoma.卵巢癌免疫反应性抗原结构域 2 控制肺腺癌中线粒体凋亡。
Cancer Sci. 2021 Dec;112(12):5114-5126. doi: 10.1111/cas.15160. Epub 2021 Oct 18.
5
Frequent aberrant methylation of the promoter region of sterile alpha motif domain 14 in pulmonary adenocarcinoma.肺腺癌中无活性α基序结构域14启动子区域频繁发生异常甲基化。
Cancer Sci. 2008 Nov;99(11):2177-84. doi: 10.1111/j.1349-7006.2008.00965.x. Epub 2008 Sep 22.
6
OCIA domain containing 2 is highly expressed in adenocarcinoma mixed subtype with bronchioloalveolar carcinoma component and is associated with better prognosis.含OCIA结构域蛋白2在具有细支气管肺泡癌成分的腺癌混合亚型中高表达,且与较好的预后相关。
Cancer Sci. 2007 Jan;98(1):50-7. doi: 10.1111/j.1349-7006.2006.00346.x.
7
OCIAD2 suppressed tumor growth and invasion via AKT pathway in Hepatocelluar carcinoma.OCIAD2通过AKT通路抑制肝癌中的肿瘤生长和侵袭。
Carcinogenesis. 2017 Sep 1;38(9):910-919. doi: 10.1093/carcin/bgx073.
8
Hypermethylation of CpG island loci and hypomethylation of LINE-1 and Alu repeats in prostate adenocarcinoma and their relationship to clinicopathological features.前列腺腺癌中CpG岛位点的高甲基化及长散在核元件1(LINE-1)和短散在核元件(Alu)重复序列的低甲基化及其与临床病理特征的关系
J Pathol. 2007 Feb;211(3):269-77. doi: 10.1002/path.2106.
9
Genome-wide analysis of methylation CpG sites in gene promoters identified four pairs of CpGs-mRNAs associated with lung adenocarcinoma prognosis.对基因启动子中甲基化CpG位点的全基因组分析确定了四对与肺腺癌预后相关的CpG-信使核糖核酸。
Gene. 2022 Feb 5;810:146054. doi: 10.1016/j.gene.2021.146054. Epub 2021 Nov 1.
10
Genome-scale meta-analysis of DNA methylation during progression of lung adenocarcinoma.肺腺癌进展过程中DNA甲基化的全基因组荟萃分析。
Genet Mol Res. 2015 Aug 7;14(3):9200-14. doi: 10.4238/2015.August.7.30.

引用本文的文献

1
Application of a risk score model based on glycosylation-related genes in the prognosis and treatment of patients with low-grade glioma.基于糖基化相关基因的风险评分模型在低级别胶质瘤患者预后和治疗中的应用。
Front Immunol. 2024 Oct 9;15:1467858. doi: 10.3389/fimmu.2024.1467858. eCollection 2024.
2
Integrative multi-omics analysis unveils the connection between transcriptomic characteristics associated with mitochondria and the tumor immune microenvironment in lower-grade gliomas.整合多组学分析揭示了与线粒体相关的转录组特征与低级别脑胶质瘤肿瘤免疫微环境之间的联系。
Sci Rep. 2024 Oct 10;14(1):23675. doi: 10.1038/s41598-024-74281-z.
3
The diagnostic value and associated molecular mechanism study for fibroblast-related mitochondrial genes on keloid.
瘢痕疙瘩中成纤维细胞相关线粒体基因的诊断价值及相关分子机制研究。
Skin Res Technol. 2024 Sep;30(9):e70024. doi: 10.1111/srt.70024.
4
Genes Co-Expressed with Influence Clinical Outcomes in Cancer Patients: TCGA Data Analysis.与癌症患者临床结局相关的基因共表达分析:TCGA 数据分析。
Int J Mol Sci. 2024 Aug 9;25(16):8707. doi: 10.3390/ijms25168707.
5
Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape.综合分析以鉴定肺腺癌的一种新型诊断标志物及其免疫浸润图谱。
Front Oncol. 2023 Jun 20;13:1199608. doi: 10.3389/fonc.2023.1199608. eCollection 2023.